Literature DB >> 30840186

Identification of miR-143 as a Major Contributor for Human Stenotic Aortic Valve Disease.

Jan Fiedler1, Da-Hee Park2,3, Lisa Hobuß2, Parnian Kalbasi Anaraki4, Angelika Pfanne2, Annette Just2,3, Saskia Mitzka2, Inna Dumler4, Frank Weidemann5, Andres Hilfiker6, Thomas Thum7,8,9,10.   

Abstract

Calcification of aortic valves leads to aortic stenosis mainly in elderly individuals, but the underlying molecular mechanisms are still not understood. Here, we studied microRNA (miR, miRNA) expression and function in healthy and stenotic human aortic valves. We identified miR-21, miR-24, and miR-143 to be highly upregulated in stenotic aortic valves. Using luciferase reporter systems, we found direct binding of miR-143 to the 3'UTR region of the matrix gla protein (MGP), which in turn is a key factor to sustain homeostasis in aortic valves. In subsequent experiments, we demonstrated a therapeutic potential of miRNA regulation during calcification in cardiac valvular interstitial cells. Collectively, our data provide evidence that deregulated miR expression contributes to the development of stenotic valve disease and thus form novel therapeutic opportunities of this severe cardiovascular disease.

Entities:  

Keywords:  Calcium deposition dependent on miR-143; Human aortic stenosis; miR signature in aortic stenosis; microRNA

Mesh:

Substances:

Year:  2019        PMID: 30840186     DOI: 10.1007/s12265-019-09880-7

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  14 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.

Authors:  Robert O Bonow; Blase A Carabello; Kanu Chatterjee; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce Whitney Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-08-01       Impact factor: 24.094

Review 3.  Introduction to aortic stenosis.

Authors:  Blase A Carabello
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

4.  Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein.

Authors:  G Luo; P Ducy; M D McKee; G J Pinero; E Loyer; R R Behringer; G Karsenty
Journal:  Nature       Date:  1997-03-06       Impact factor: 49.962

5.  Prevalence and characteristics of unoperated patients with severe aortic stenosis.

Authors:  David S Bach
Journal:  J Heart Valve Dis       Date:  2011-05

6.  An epigenetic regulatory loop controls pro-osteogenic activation by TGF-β1 or bone morphogenetic protein 2 in human aortic valve interstitial cells.

Authors:  Rui Song; David A Fullerton; Lihua Ao; Ke-Seng Zhao; Xianzhong Meng
Journal:  J Biol Chem       Date:  2017-04-04       Impact factor: 5.157

7.  MicroRNA-24 regulates vascularity after myocardial infarction.

Authors:  Jan Fiedler; Virginija Jazbutyte; Bettina C Kirchmaier; Shashi K Gupta; Johan Lorenzen; Dorothee Hartmann; Paolo Galuppo; Susanne Kneitz; John T G Pena; Cherin Sohn-Lee; Xavier Loyer; Juergen Soutschek; Thomas Brand; Thomas Tuschl; Joerg Heineke; Ulrich Martin; Stefan Schulte-Merker; Georg Ertl; Stefan Engelhardt; Johann Bauersachs; Thomas Thum
Journal:  Circulation       Date:  2011-07-25       Impact factor: 29.690

8.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.

Authors:  Thomas Thum; Carina Gross; Jan Fiedler; Thomas Fischer; Stephan Kissler; Markus Bussen; Paolo Galuppo; Steffen Just; Wolfgang Rottbauer; Stefan Frantz; Mirco Castoldi; Jürgen Soutschek; Victor Koteliansky; Andreas Rosenwald; M Albert Basson; Jonathan D Licht; John T R Pena; Sara H Rouhanifard; Martina U Muckenthaler; Thomas Tuschl; Gail R Martin; Johann Bauersachs; Stefan Engelhardt
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

9.  Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster.

Authors:  Thomas Boettger; Nadine Beetz; Sawa Kostin; Johanna Schneider; Marcus Krüger; Lutz Hein; Thomas Braun
Journal:  J Clin Invest       Date:  2009-08-17       Impact factor: 14.808

10.  Cardiac Fibroblasts Adopt Osteogenic Fates and Can Be Targeted to Attenuate Pathological Heart Calcification.

Authors:  Indulekha C L Pillai; Shen Li; Milagros Romay; Larry Lam; Yan Lu; Jie Huang; Nathaniel Dillard; Marketa Zemanova; Liudmilla Rubbi; Yibin Wang; Jason Lee; Ming Xia; Owen Liang; Ya-Hong Xie; Matteo Pellegrini; Aldons J Lusis; Arjun Deb
Journal:  Cell Stem Cell       Date:  2016-11-17       Impact factor: 25.269

View more
  2 in total

Review 1.  A systematic review of micro-RNAs in aortic stenosis and cardiac fibrosis.

Authors:  Jemima Osekafore Adewuyi; Roshan Patel; Riccardo Abbasciano; Gerry P McCann; Gavin Murphy; Marcin J Woźniak; Anvesha Singh
Journal:  Clin Transl Sci       Date:  2022-05-21       Impact factor: 4.438

Review 2.  Aortic valve calcification in the era of non-coding RNAs: The revolution to come in aortic stenosis management?

Authors:  Joseph Nader; Laurent Metzinger; Pierre Maitrias; Thierry Caus; Valérie Metzinger-Le Meuth
Journal:  Noncoding RNA Res       Date:  2020-02-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.